Q2 EPS Forecast for Abeona Therapeutics Reduced by Analyst
Abeona Therapeutics Inc (NASDAQ:ABEO – Free Report) – Analysts at HC Wainwright decreased their Q2 2025 earnings per share (EPS) estimates for shares of Abeona Therapeutics in a research report issued on Monday, May 19th. HC Wainwright analyst R. Selvaraju now forecasts that the biopharmaceutical company will earn ($0.39) per share for the quarter, down […]
